ClinicalTrials.Veeva

Menu

Dachaihu Decoction Compound and Rhubarb Single Medicine in the Treatment of Acute Pancreatitis

F

Fifth Affiliated Hospital, Sun Yat-Sen University

Status

Not yet enrolling

Conditions

Acute Pancreatitis

Treatments

Combination Product: Regular therapies
Drug: Rhubarb single medicine
Combination Product: Dachaihu decoction compound

Study type

Interventional

Funder types

Other

Identifiers

NCT04990336
ZDWY.XHNK.003

Details and patient eligibility

About

A large number of clinical studies have shown that oral administration, external application or enema of Chinese medicine can promote the recovery of gastrointestinal function and the absorption of pancreatic inflammation. The aims of the study is to explore the application of Dachaihu Decoction Compound (DDC)and Rhubarb Single Medicine (RSM) in the Treatment of Acute Pancreatitis.

Enrollment

306 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age from 18 to 65 years old
  • Meet the diagnostic criteria of western medicine for acute pancreatitis, within 48 hours of onset
  • Consent of the subjects, who sign the informed consent form

Exclusion criteria

  • Women who are pregnant or breastfeeding
  • Acute abdomen such as organic intestinal obstruction, gastrointestinal perforation, purulent cholangitis, etc.
  • Patients with a history of severe heart, liver, kidney and other important organ diseases
  • Patients with mental illness and malignant tumors
  • People who have allergies, or are allergic to a certain drug ingredient

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

306 participants in 3 patient groups

DDC(Dachaihu decoction compound) Group
Experimental group
Description:
Treated with Dachaihu decoction compound and regular therapies
Treatment:
Combination Product: Regular therapies
Combination Product: Dachaihu decoction compound
RSM(rhubarb single medicine) Group
Active Comparator group
Description:
Treated with rhubarb single medicine and regular therapies
Treatment:
Combination Product: Regular therapies
Drug: Rhubarb single medicine
N Group
Other group
Description:
Treated with regular therapies and without traditional Chinese medicine
Treatment:
Combination Product: Regular therapies

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems